Company intelligence
American Brain Foundation
We bring researchers and donors together to cure brain diseases and disorders.
About American Brain Foundation
Since 1992, the American Brain Foundation has been investing in research to end the battle against brain diseases and disorders. We are a national foundation in relentless pursuit to identify causes, improve treatments, and discover cures. We unite donors and researchers to impact patient lives and those around them. We invest in research of the whole brain and all nervous system disorders knowing they are interconnected. This holistic, innovative approach allows us to build bridges between diseases and break new ground in research and application. Believing in a whole-brain approach gives us an edge in understanding and combating brain disease. We understand that when we cure one of them, we will cure many. Learn more by visiting www.AmericanBrainFoundation.org. Mission: The American Brain Foundation brings researchers and donors together to cure brain diseases and disorders. Vision: Life without brain disease.
Verified activity
Signals from American Brain Foundation
7 published signals
Presence & Recognition
American Brain Foundation honored the cast and writers of Apple TV's Shrinking series with the 2026 Advocate Award at the American Brain Foundation Gala in Nashville on September 12.
Reported by American Brain Foundation
Products & Services
American Brain Foundation updated its Brain Diseases from A–Z webpage to add information about Charcot-Marie-Tooth Disease, including symptoms, diagnosis, and research.
Reported by American Brain Foundation
Research & Knowledge
American Brain Foundation awarded a Next Generation Research Grant to Amy Waldman, MD, who led studies culminating in the FDA approval of the first-ever treatment for Alexander disease, Zanvastro (zilganersen), administered via spinal injection.
Reported by American Brain Foundation
Research & Knowledge
American Brain Foundation recognizes the importance of prevention and lifelong brain health, with donors funding studies exploring brain disease risk.
Reported by American Brain Foundation
Research & Knowledge
American Brain Foundation notes that the World Health Organization released updated guidelines on reducing the risk of dementia and cognitive decline, noting that 45% of dementia risk can be attributed to modifiable factors.
Reported by American Brain Foundation
Research & Knowledge
American Brain Foundation reported that the FDA cleared a new blood test called PrecivityAD2 developed by Randall J. Bateman, MD and David M. Holtzman, MD from Washington University in St. Louis to detect amyloid plaque biomarkers with over 90% accuracy.
Reported by American Brain Foundation
Research & Knowledge
American Brain Foundation noted that 1998 Next Generation Research Grant recipient Reina A. Sperling, MD, at Harvard Medical School is a co-author of a new study evaluating another technology designed to test blood for Alzheimer’s using a prototype immunoassay detection tool from Elecsys.
Reported by American Brain Foundation